Trending News

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced that new efficacy and safety data from the Phase 3 pivotal SAPPHIRE trial (NCT05156320) will be presented in multiple clinical presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical &a
Read More

Some animals’ natural biological defenses could inspire new approaches to cancer prevention and treatment in humans

Researchers have long known that diet exerts a profound influence on health, including the risk of developing cancer. A new study, led by researchers at Arizona State University, explores the relationship among diet, blood sugar (specifically glucose) and cancer prevalence across a broad range of vertebrate species.
Read More

Vocal changes in songbirds may help predict age-related disorders in people, neuroscientists suggest

University of Arizona neuroscientists studying the brains of songbirds have found that aging alters the gene expressions that control the birds’ song. The finding could lead to earlier diagnoses and better treatments for human neurodegenerative disorders such as Parkinson’s disease and Alzheimer’s disease, which are known to hinder vocal production in their early stages.
Read More

Prototype device uses ultrasound to break up kidney stones

A team from the Universitat Politècnica de València (UPV) and the Spanish National Research Council (CSIC), belonging to the Research Institute for Molecular Imaging Technologies (I3M), has developed, together with the NITIUV Group of the La Fe Health Research Institute (IIS La Fe) in Valencia and the Biomechanics Institute of Valencia, a new device—in the prototype phase—to break up kidney stones.
Read More
Top